Core Viewpoint - The company emphasizes enhancing operational quality as its core focus, aiming to solidify its operational foundation through various strategies [1] Group 1 - The company plans to optimize its product structure to improve efficiency [1] - The company aims to reduce costs and increase efficiency as part of its operational strategy [1] - The company is looking to expand its customer base by targeting high-quality clients [1] - The company intends to seize opportunities in overseas markets to bolster growth [1]

Group 1: Financial Performance - In the first half of 2025, the company achieved revenue of 2.417 billion yuan, a decrease of 14.55% compared to the same period last year [2] - The non-recurring net profit loss was 49 million yuan, significantly narrowing compared to the previous year [2] - The overall gross margin improved from approximately 26% in 2024 to nearly 30% in the first half of 2025, indicating enhanced operational and contract quality [4] Group 2: Business Strategy and Operations - The company is focusing on improving operational quality, with efforts including increased international business expansion, which saw nearly 40% growth in overseas revenue in the first half of 2025 [2] - Domestic order quality is improving, with new order gross margins gradually returning to normal levels despite intense competition in the domestic market [2] - The company is actively pursuing cost reduction and efficiency improvements across management, R&D, procurement, and manufacturing [2] Group 3: International Business Development - The company’s international business has seen significant changes, with major pharmaceutical companies beginning supplier audits, leading to breakthroughs in cooperation [3] - In the first half of 2025, the company experienced strong growth in the Middle East and Southeast Asia, with hopes of increasing the proportion of international business in the coming years [2][3] - Romaco Group, a subsidiary, is performing well with steady improvements, and currently has no plans for further overseas capacity expansion [3] Group 4: Market Conditions and Competition - The domestic market remains competitive, with price sensitivity; however, the price competition has improved compared to last year, suggesting a bottoming out of pricing pressures [3] - The company plans to selectively abandon low-margin orders to enhance operational quality while maintaining scale [3]

Group 1 - The company focuses on its core business and aims to enhance operational quality and product strength [1] - The company maintains ongoing communication and interaction with the capital market [1]

Core Viewpoint - The company emphasizes its commitment to enhancing intrinsic value through technological innovation and operational efficiency, while maintaining transparent communication with the market and shareholders [1] Group 1 - The company is closely monitoring stock price fluctuations, acknowledging that secondary market prices are influenced by multiple external factors, leading to short-term volatility [1] - The company is dedicated to improving operational efficiency and strengthening market competitiveness to solidify its fundamentals [1] - The company is committed to fulfilling information disclosure obligations and actively engaging in shareholder return responsibilities [1] Group 2 - The company believes that by continuously improving operational quality, optimizing governance structures, and actively rewarding shareholders, market value will achieve dynamic balance with intrinsic value [1] - The company will continue to focus on its core business development to provide long-term performance returns to investors [1] - The company plans to disclose specific operational results in its upcoming periodic report on August 26 [1]

Core Viewpoint - The company emphasizes its commitment to enhancing operational quality and governance to support national strategic security and development needs [1][2]. Group 1: Operational Focus - The company will concentrate on its core business, leveraging its capabilities and technological advantages to improve the research and manufacturing levels of its main products [1]. - The company aims to enhance value creation by implementing cost control measures and performance assessments, focusing on efficiency and effectiveness [1]. Group 2: Governance Improvement - The company plans to revise governance systems in accordance with the Company Law and improve the governance structure to enhance operational efficiency [2]. - There will be a focus on strengthening the role of independent directors to improve decision-making efficiency and operational effectiveness [2]. - The company will enhance compliance management and risk monitoring to prevent and mitigate major risks, ensuring robust audit supervision [2]. Group 3: Transparency and Investor Relations - The company will continue to fulfill its information disclosure obligations to improve transparency and protect investors' rights [3]. - There will be an emphasis on deepening investor relations management and increasing communication with the capital market [3].